Advertisement
Canada markets closed

  • S&P/TSX

    22,465.37
    +165.54 (+0.74%)
     

  • S&P 500

    5,303.27
    +6.17 (+0.12%)
     

  • DOW

    40,003.59
    +134.21 (+0.34%)
     

  • CAD/USD

    0.7348
    +0.0002 (+0.03%)
     

  • CRUDE OIL

    80.00
    +0.77 (+0.97%)
     

  • Bitcoin CAD

    91,183.04
    +2,114.27 (+2.37%)
     

  • CMC Crypto 200

    1,367.15
    -6.69 (-0.49%)
     

  • GOLD FUTURES

    2,419.80
    +34.30 (+1.44%)
     

  • RUSSELL 2000

    2,095.72
    -0.53 (-0.03%)
     

  • 10-Yr Bond

    4.4200
    +0.0430 (+0.98%)
     

  • NASDAQ

    16,685.97
    -12.35 (-0.07%)
     

  • VOLATILITY

    11.99
    -0.43 (-3.46%)
     

  • FTSE

    8,420.26
    -18.39 (-0.22%)
     

  • NIKKEI 225

    38,787.38
    -132.88 (-0.34%)
     

  • CAD/EUR

    0.6755
    -0.0001 (-0.01%)
     

Owens & Minor (OMI) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Equity Research
·2 min read

Owens & Minor (OMI) reported $2.61 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 3.6%. EPS of $0.19 for the same period compares to $0.05 a year ago.

The reported revenue represents a surprise of -0.40% over the Zacks Consensus Estimate of $2.62 billion. With the consensus EPS estimate being $0.17, the EPS surprise was +11.76%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

ADVERTISEMENT

Here is how Owens & Minor performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net revenue- Patient Direct: $637.84 million versus $657.49 million estimated by two analysts on average.

  • Net revenue- Products & Healthcare Services: $1.97 billion compared to the $1.97 billion average estimate based on two analysts.

  • Operating income (loss)- Patient Direct: $45.88 million compared to the $50.46 million average estimate based on two analysts.

  • Operating income (loss)- Products & Healthcare Services: $11.49 million compared to the $15.20 million average estimate based on two analysts.

View all Key Company Metrics for Owens & Minor here>>>

Shares of Owens & Minor have returned -8.2% over the past month versus the Zacks S&P 500 composite's -2.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Owens & Minor, Inc. (OMI) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research